Competition watchdog finds new target: overpriced generics.
作者信息
Hawkes Nigel
机构信息
London.
出版信息
BMJ. 2016 Dec 14;355:i6712. doi: 10.1136/bmj.i6712.
PMID:27974337
Abstract
摘要
相似文献
1
Competition watchdog finds new target: overpriced generics.
BMJ. 2016 Dec 14;355:i6712. doi: 10.1136/bmj.i6712.
2
The "reverse payment paradox": an overview of the legality of reverse exclusionary payments in the pharmaceutical industry.“反向支付悖论”：制药行业反向排他性支付的合法性概述
Health Care Law Mon. 2010 Mar;2010(3):2-10.
3
A generic problem.一个一般性问题。
Nat Clin Pract Gastroenterol Hepatol. 2006 Dec;3(12):649. doi: 10.1038/ncpgasthep0659.
4
Price regulation and generic competition in the pharmaceutical market.药品市场中的价格管制与仿制药竞争
Eur J Health Econ. 2006 Sep;7(3):208-14. doi: 10.1007/s10198-006-0357-y.
5
Delaying generic competition--corporate payoffs and the future of Plavix.延迟仿制药竞争——企业收益与波立维的未来
N Engl J Med. 2006 Sep 28;355(13):1297-300. doi: 10.1056/NEJMp068193.
6
A shift on "pay for delay"--reopening doors for pharmaceutical competition?“支付延迟”的转变——为药品竞争重新打开大门？
N Engl J Med. 2012 Nov 1;367(18):1681-3. doi: 10.1056/NEJMp1209693.
7
Targeting Unconscionable Prescription-Drug Prices - Maryland's Anti-Price-Gouging Law.针对不合理的处方药价格——马里兰州的反价格欺诈法。
N Engl J Med. 2017 Jul 13;377(2):101-103. doi: 10.1056/NEJMp1704907. Epub 2017 Jun 7.
8
Reanalyzing reverse payment settlements: a solution to the patentee's dilemma.重新分析反向支付和解协议：专利权人困境的解决方案。
Cornell Law Rev. 2014 Jul;99(5):1227-58.
9
Branded drug reformulation: the next brand vs. generic antitrust battleground.品牌药重新配方：下一个品牌药与仿制药反垄断战场。
Food Drug Law J. 2007;62(1):249-56.
10
A trade agreement's impact on access to generic drugs.贸易协定对获得仿制药的影响。
Health Aff (Millwood). 2009 Sep-Oct;28(5):w957-68. doi: 10.1377/hlthaff.28.5.w957. Epub 2009 Aug 25.
Zotero 插件